Improvement in survival of acute myeloid leukemia and myelodysplastic syndrome patients following allogeneic transplant: a long-term institutional experience

Improvement in survival of acute myeloid leukemia and myelodysplastic syndrome patients following allogeneic transplant: a long-term institutional experience

BackgroundAllogeneic stem cell transplant (allo-SCT) plays a key role in the treatment of patients with both acute myeloid leukemia (AML) and myelodysplastic (MDS). Outcomes of allo-SCT have improved with optimization of transplant practices. We sought to evaluate trends in survival in AML and MDS p...

Full description

Bibliographic Details
Main Authors: Audrey M. Sigmund, Justin Jiang, Qiuhong Zhao, Patrick Elder, Don M. Benson, Sumithira Vasu, Samantha Jaglowski, Alice S. Mims, Hannah Choe, Karilyn Larkin, Jonathan E. Brammer, Sarah A. Wall, Nicole Grieselhuber, William Basem, Sam Penza, Yvonne A. Efebera, Nidhi Sharma
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-10-01
Series:Frontiers in Hematology
Subjects:
acute myeloid leukemia
allogenic transplantation
overall survival
progression-free survival
graft-versus-host disease
Online Access:https://www.frontiersin.org/articles/10.3389/frhem.2023.1274649/full

Internet

https://www.frontiersin.org/articles/10.3389/frhem.2023.1274649/full

Similar Items